94 related articles for article (PubMed ID: 12629717)
1. [Anti hyperuricemic agents].
Ogino K; Hisatome I; Shigemasa C
Nihon Rinsho; 2003 Jan; 61 Suppl 1():197-201. PubMed ID: 12629717
[No Abstract] [Full Text] [Related]
2. [Uricosuric agent].
Ohno I
Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
[TBL] [Abstract][Full Text] [Related]
3. [Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects].
Yamanaka H
Nihon Rinsho; 2003 Jan; 61 Suppl 1():202-8. PubMed ID: 12629718
[No Abstract] [Full Text] [Related]
4. Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats.
Schwartz IF; Grupper A; Chernichovski T; Grupper A; Hillel O; Engel A; Schwartz D
J Vasc Res; 2011; 48(3):252-60. PubMed ID: 21099230
[TBL] [Abstract][Full Text] [Related]
5. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ureogenesis by two hypouricemic drugs (probenecid and benzbromarone). Comparison with allopurinol.
Sanchez-Beltran MJ; Rodilla F; Gomez-Ruiz MD; Izquierdo R; Cabo J
Cell Mol Biol; 1988; 34(6):649-54. PubMed ID: 3219699
[No Abstract] [Full Text] [Related]
7. Stopping progression in familial juvenile hyperuricemic nephropathy with benzbromarone?
Lhotta K
Kidney Int; 2003 Nov; 64(5):1920-1. PubMed ID: 14531831
[No Abstract] [Full Text] [Related]
8. Clinical efficacy and safety of benzbromarone in elderly hypertensive patients with hyperuricemia.
Gao H
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1869-1871. PubMed ID: 31680085
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
Hanvivadhanakul P; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism in biological transport in the kidney: Urate transporter URAT1].
Hosoyamada M; Shibasaki T; Ichida K
Nihon Rinsho; 2006 Feb; 64 Suppl 2():176-9. PubMed ID: 16523883
[No Abstract] [Full Text] [Related]
11. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
[TBL] [Abstract][Full Text] [Related]
12. [The effect of uricosuric and uricostatic drugs on DNA metabolism].
Klein G; Wottawa A; Rainer F
Acta Med Austriaca; 1976; 3(3):91-7. PubMed ID: 1002459
[TBL] [Abstract][Full Text] [Related]
13. Approach to the treatment of hyperuricemia.
Poon SH; Hall HA; Zimmermann B
Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
[No Abstract] [Full Text] [Related]
14. Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: Two case reports.
Ye X; Wu J; Tang K; Li W; Xiong C; Zhuo L
Medicine (Baltimore); 2019 Apr; 98(15):e15214. PubMed ID: 30985721
[TBL] [Abstract][Full Text] [Related]
15. [How to select and use urate lowering agents for hyperuricemia].
Yamanaka H
Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
[TBL] [Abstract][Full Text] [Related]
16. Letter by George regarding article, "Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled cross-over preliminary study".
George J
Circ Heart Fail; 2010 May; 3(3):e10; author reply e14. PubMed ID: 20484184
[No Abstract] [Full Text] [Related]
17. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
Wong ML
N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907
[No Abstract] [Full Text] [Related]
18. Fatal fulminant hepatic failure associated with benzbromarone.
Wagayama H; Shiraki K; Sugimoto K; Fujikawa K; Shimizu A; Takase K; Nakano T; Tameda Y
J Hepatol; 2000 May; 32(5):874. PubMed ID: 10845680
[No Abstract] [Full Text] [Related]
19. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
Matzkies F
Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
[No Abstract] [Full Text] [Related]
20. Fulminant hepatic failure associated with benzbromarone treatment: a case report.
Arai M; Yokosuka O; Fujiwara K; Kojima H; Kanda T; Hirasawa H; Saisho H
J Gastroenterol Hepatol; 2002 May; 17(5):625-6. PubMed ID: 12084041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
